Cenci, Tonia
 Distribuzione geografica
Continente #
EU - Europa 2.960
NA - Nord America 2.887
AS - Asia 1.225
AF - Africa 15
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 7.100
Nazione #
US - Stati Uniti d'America 2.873
DE - Germania 1.322
CN - Cina 789
SE - Svezia 499
IT - Italia 264
UA - Ucraina 218
SG - Singapore 210
IE - Irlanda 133
FR - Francia 116
GB - Regno Unito 116
PL - Polonia 94
ID - Indonesia 77
FI - Finlandia 72
RU - Federazione Russa 52
TR - Turchia 49
IN - India 46
BE - Belgio 20
CI - Costa d'Avorio 13
IR - Iran 12
JP - Giappone 12
HK - Hong Kong 10
NL - Olanda 10
CA - Canada 9
VN - Vietnam 9
LT - Lituania 8
CH - Svizzera 7
ES - Italia 7
AT - Austria 6
EU - Europa 4
MX - Messico 4
RO - Romania 4
AU - Australia 3
KR - Corea 3
NO - Norvegia 3
BR - Brasile 2
CZ - Repubblica Ceca 2
LK - Sri Lanka 2
MD - Moldavia 2
SA - Arabia Saudita 2
TW - Taiwan 2
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CL - Cile 1
CM - Camerun 1
EC - Ecuador 1
GR - Grecia 1
IL - Israele 1
KW - Kuwait 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
RS - Serbia 1
ZA - Sudafrica 1
Totale 7.100
Città #
Ashburn 626
Chandler 513
Hangzhou 313
Singapore 171
Jacksonville 140
Dublin 133
San Mateo 110
Nanjing 104
Nürnberg 98
Beijing 90
Ann Arbor 89
Wilmington 84
Warsaw 82
Jakarta 77
Woodbridge 74
New York 65
Dearborn 64
Houston 64
Fairfield 57
Seattle 51
Cattolica 49
Izmir 48
Nanchang 42
Boston 39
Moscow 38
Lawrence 37
Milan 37
Los Angeles 36
Princeton 33
Rome 32
Bremen 31
Redwood City 31
Kunming 29
Helsinki 28
Munich 27
Redmond 25
Marseille 24
Chicago 22
Lancaster 21
Mountain View 20
Shenyang 20
Brussels 17
Hebei 17
Cambridge 15
Shanghai 15
Jiaxing 14
Norwalk 14
Abidjan 13
Guangzhou 12
Leawood 12
Tianjin 12
Boardman 11
Kraków 11
Paris 11
Changsha 10
Fremont 9
University Park 9
Zhengzhou 9
Auburn Hills 8
Augusta 7
Berlin 7
Hefei 7
Hong Kong 7
Jinan 7
London 7
Naples 7
Pune 7
Bedizzole 6
Detroit 6
Edinburgh 6
Frankfurt am Main 6
Verona 6
Vienna 6
Dong Ket 5
Gunzenhausen 5
Lanzhou 5
Simi Valley 5
Bern 4
Changchun 4
Indiana 4
Ladispoli 4
Mumbai 4
Orange 4
Pomigliano d'Arco 4
San Diego 4
Santa Clara 4
Stockholm 4
Washington 4
Andover 3
Falls Church 3
Florence 3
Hanoi 3
Islington 3
Kish 3
Madrid 3
Mcallen 3
Monmouth Junction 3
Northbrook 3
Padova 3
Palermo 3
Totale 4.085
Nome #
Discordance of KRAS Mutational Status between Primary Tumors and Liver Metastases in Colorectal Cancer: Impact on Long-Term Survival Following Radical Resection 511
Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells 446
Diagnostic and prognostic role of HBME-1, galectin-3, and β-catenin in poorly differentiated and anaplastic thyroid carcinomas 368
Is there a role for IGF1R and c-MET pathways in resistance to cetuximab in metastatic colorectal cancer? 252
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents 206
C-myc expression is a possible keystone in the colorectal cancer resistance to egfr inhibitors 203
KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients 184
Von hippel-lindau disease and erythrocytosis 151
Analysis of immunocytochemical and molecular BRAF expression in thyroid carcinomas: A cytohistologic institutional experience 149
Diagnostic and prognostic value of immunocytochemistry and braf mutation analysis on liquid based biopsies of thyroid neoplasms suspicious for carcinoma. 137
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma 136
Different STAT-3 and STAT-5 phosphorylation discriminates among Ph-negative chronic myeloproliferative diseases and is independent of the V617F JAK-2 mutation. 132
PDGFRA-mutant syndrome 132
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma 127
Case of Rectal GI Stromal Tumor Demonstrating that KIT and PDGFRA Mutations Are Not Always Mutually Exclusive 127
c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors. 125
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma. 109
KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study 109
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 108
Hereditary thrombocytosis caused by MPLSer505Asn is associated with a high thrombotic risk, splenomegaly and progression to bone marrow fibrosis 102
Epigenetic silencing of Id4 identifies a glioblastoma subgroup with a better prognosis as a consequence of an inhibition of angiogenesis. 100
The revised WHO diagnostic criteria for Ph-negative myeloproliferative diseases are not appropriate for the diagnostic screening of childhood polycythemia vera and essential thrombocythemia 98
Expression of EGFRvIII in glioblastoma: prognostic significance revisited. 98
Circulating hematopoietic stem cells and putative intestinal stem cells in coeliac disease 98
Chemotherapy of skull base chordoma tailored on responsiveness of patient-derived tumor cells to rapamycin 91
The mutant JAK2 allele burden in children with essential thrombocythemia 89
Endothelial progenitor cells are clonal and exhibit the JAK2(V617F) mutation in a subset of thrombotic patients with Ph-negative myeloproliferative neoplasms 86
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 84
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma 82
Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights 82
Endothelial progenitor cells are clonal and exhibit the JAK2(V617F) mutation in a subset of thrombotic patients with Ph-negative myeloproliferative neoplasms 81
Epigenetic alteration of SOCS family members is a possible pathogenetic mechanism in JAK2 wild type myeloproliferative diseases 80
The evaluation of miRNAs on thyroid FNAC: the promising role of miR-375 in follicular neoplasms 79
Thrombopoietin receptor activation, thrombopoietin mimetic drugs, and hereditary thrombocytosis: remarks on bone marrow fibrosis 78
A novel heterozygous HIF2AM535I mutation reinforces the role of oxygen sensing pathway disturbances in the pathogenesis of familial erythrocytosis 78
Prognostic relevance of c-Myc and BMI1 expression in patients with glioblastoma 78
The bladder epicheck test and cytology in the follow-up of patients with non-muscle-invasive high grade bladder carcinoma 77
The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment response 74
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents 72
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma 71
Divergent gastrointestinal stromal tumors in syndromic settings 66
Chemotherapy of Skull Base Chordoma Tailored on Responsiveness of Patient-Derived Tumor Cells to Rapamycin1,2 66
Eight-year survival of a recurrent glioblastoma patient treated with molecularly tailored therapy: a case report 66
Plexiform architecture in gastrointestinal stromal tumors is not restricted to succinate dehydrogenase-deficient cases 65
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation 64
Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia 62
Prognostic relevance of SOCS3 hypermethylation in patients with glioblastoma multiforme 61
Tailored therapy for recurrent glioblastoma. Report of a personalized molecular approach 58
how limited molecular testing can also offer diagnostic and prognostic evaluation of thyroid nodules processed with liquid based cytology. Role of TERT promoter and BRAF V600E mutation analysis 56
Characterization of variants in the promoter of EBV gene BZLF1 in normal donors, HIV-positive patients and in AIDS-related lymphomas 55
Methylation study of the Paris system for reporting urinary (TPS) categories 55
Morphology combined with ancillary techniques: An algorithm approach for thyroid nodules 54
Clinical and NGS predictors of response to regorafenib in recurrent glioblastoma 52
SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System 50
Morphology combined with ancillary techniques: An algorithm approach for thyroid nodules 50
Pituitary-tumour-transforming-gene 1 expression in testicular cancer 49
The combination cytology/epichek test in non muscle invasive bladder carcinoma follow-up: Effective tool or useless expence? 49
Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis 48
Epigenetic Silencing of Id4 Identifies a Glioblastoma Subgroup With a Better Prognosis as a Consequence of an Inhibition of Angiogenesis 47
To obtain more with less cytologic samples with ancillary molecular techniques-the useful role of liquid-based cytology 47
Protein Expression of PTTG-1, OCT-4, and KLF-4 in Seminoma: A Pilot Study. 47
The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment response 43
The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment response 42
Epigenetic silencing of Id4 identifies a glioblastoma subgroup with a better prognosis as a consequence of an inhibition of angiogenesis 39
Case of Rectal GI Stromal Tumor Demonstrating that KIT and PDGFRA Mutations Are Not Always Mutually Exclusive 39
The role of thyroid FNA cytology in pediatric malignant lesions: An overview of the literature 38
Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis 37
DNA methylation analysis in urinary samples: A useful method to predict the risk of neoplastic recurrence in patients with urothelial carcinoma of the bladder in the high-risk group 34
Chemotherapy of skull base chordoma tailored on responsiveness of patient-derived tumor cells to rapamycin 33
Erratum: Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells (Nature (2010) 468 (824-828)) 32
The Immunohistochemical Analysis of SOCS3 Protein Identifies a Subgroup of Prostatic Cancer Biopsies with Aggressive Behavior 32
PTTG1/ZEB1 Axis Regulates E-Cadherin Expression in Human Seminoma 31
Telomerase inhibition in malignant gliomas. A systematic review 30
The Immunohistochemical Analysis of SOCS3 Protein Identifies a Subgroup of Prostatic Cancer Biopsies With Aggressive Behavior 30
Dissecting Stemness in Aggressive Intracranial Meningiomas: Prognostic Role of SOX2 Expression 25
Upper urothelial tract high-grade carcinoma: comparison of urine cytology and DNA methylation analysis in urinary samples. 22
SPTBN1 Mediates the Cytoplasmic Constraint of PTTG1, Impairing Its Oncogenic Activity in Human Seminoma 20
Paths of Evolution of Progressive Anaplastic Meningiomas: A Clinical and Molecular Pathology Study 11
Totale 7.195
Categoria #
all - tutte 27.956
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.956


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020508 0 0 0 0 0 0 127 55 83 47 117 79
2020/2021642 48 101 53 56 76 43 53 7 74 26 91 14
2021/2022679 73 44 18 65 58 20 16 97 28 48 90 122
2022/20231.388 203 205 105 217 93 164 56 87 162 28 48 20
2023/20241.129 27 210 25 50 16 95 265 261 6 30 68 76
2024/2025393 34 30 124 42 108 51 4 0 0 0 0 0
Totale 7.195